lomefloxacin has been researched along with Recrudescence in 7 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nine centers in Italy participated in a worldwide, multicenter study comparing the effectiveness and safety of lomefloxacin and amoxicillin in patients with acute exacerbations of chronic bronchitis caused mainly by gram-negative pathogens." | 9.07 | Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study. ( Albera, C; Grassi, C; Pozzi, E, 1992) |
| "In two multicenter trials, lomefloxacin and cefaclor were compared as treatments for acute bacterial exacerbations of chronic bronchitis." | 9.07 | Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis. ( Ellison, WT; Gotfried, MH, 1992) |
| "The efficacy and safety of two fluoroquinolone antimicrobial agents, lomefloxacin and ciprofloxacin, were compared in a randomized, investigator-blinded, multiple-dose study that enrolled 150 adult outpatients with complicated or recurrent urinary tract infections." | 9.07 | A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. ( Cox, CE, 1992) |
| "To objectively evaluate the efficacy, safety and utility of lomefloxacin (NY-198), a new quinolone antibacterial agent, in the treatment of acute uncomplicated cystitis, a comparative double blind trial was performed using norfloxacin (NFLX) as the control drug." | 9.06 | [A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis]. ( Amano, M; Arakawa, S; Fujita, Y; Ishigami, J; Kamidono, S; Kanemasa, Y; Kumon, H; Ohmori, H; Suzuki, K; Tanaka, H, 1989) |
| "Nine centers in Italy participated in a worldwide, multicenter study comparing the effectiveness and safety of lomefloxacin and amoxicillin in patients with acute exacerbations of chronic bronchitis caused mainly by gram-negative pathogens." | 5.07 | Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study. ( Albera, C; Grassi, C; Pozzi, E, 1992) |
| "In two multicenter trials, lomefloxacin and cefaclor were compared as treatments for acute bacterial exacerbations of chronic bronchitis." | 5.07 | Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis. ( Ellison, WT; Gotfried, MH, 1992) |
| "The efficacy and safety of two fluoroquinolone antimicrobial agents, lomefloxacin and ciprofloxacin, were compared in a randomized, investigator-blinded, multiple-dose study that enrolled 150 adult outpatients with complicated or recurrent urinary tract infections." | 5.07 | A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. ( Cox, CE, 1992) |
| "To objectively evaluate the efficacy, safety and utility of lomefloxacin (NY-198), a new quinolone antibacterial agent, in the treatment of acute uncomplicated cystitis, a comparative double blind trial was performed using norfloxacin (NFLX) as the control drug." | 5.06 | [A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis]. ( Amano, M; Arakawa, S; Fujita, Y; Ishigami, J; Kamidono, S; Kanemasa, Y; Kumon, H; Ohmori, H; Suzuki, K; Tanaka, H, 1989) |
| "Confirmation of recurrence was carried out to the greatest extent possible." | 2.68 | [Long-term monitoring of female acute uncomplicated cystitis cases after lomefloxacin single-dose therapy]. ( Aoki, M; Hirose, T; Kumamoto, Y; Miyake, M; Sakai, S; Shibuya, A; Shimamura, S; Takatsuka, K; Umehara, T; Yamazaki, K, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, T | 1 |
| Kumamoto, Y | 1 |
| Sakai, S | 1 |
| Shimamura, S | 1 |
| Shibuya, A | 1 |
| Yamazaki, K | 1 |
| Umehara, T | 1 |
| Miyake, M | 1 |
| Takatsuka, K | 1 |
| Aoki, M | 1 |
| Savitskaia, KI | 1 |
| Trapeznikova, MF | 1 |
| Nekhorosheva, AG | 1 |
| Solodilova, OE | 1 |
| Nasonov, VN | 1 |
| Dutov, VV | 1 |
| Kalinin, VN | 1 |
| Shanina, AG | 1 |
| Rusanova, EV | 1 |
| Guibert, J | 1 |
| Herman, H | 1 |
| Capron, MH | 1 |
| Grassi, C | 1 |
| Albera, C | 1 |
| Pozzi, E | 1 |
| Gotfried, MH | 1 |
| Ellison, WT | 1 |
| Cox, CE | 1 |
| Ohmori, H | 1 |
| Kumon, H | 1 |
| Suzuki, K | 1 |
| Kamidono, S | 1 |
| Arakawa, S | 1 |
| Ishigami, J | 1 |
| Tanaka, H | 1 |
| Amano, M | 1 |
| Fujita, Y | 1 |
| Kanemasa, Y | 1 |
7 trials available for lomefloxacin and Recrudescence
| Article | Year |
|---|---|
[Long-term monitoring of female acute uncomplicated cystitis cases after lomefloxacin single-dose therapy].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Double-Blind Me | 1995 |
[Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Mal | 1994 |
[Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
Topics: Adult; Anti-Infective Agents; Cystitis; Drug Administration Schedule; Female; Fluoroquinolones; Huma | 1997 |
Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chroni | 1992 |
Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefaclor; Chronic | 1992 |
A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; F | 1992 |
[A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Child; Clinical Trials as T | 1989 |